Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA clears test for kidney transplant patients
You may also be interested in...
Quest Diagnostics Snags Thermo Fisher’s Neuro Testing Lab Biz For $740 Mil.
Thermo Fisher Scientific is selling two diagnostic services units, including its Athena Diagnostics neurology testing business, for a total of $940 million, the company announced Feb. 24.
Quest Diagnostics Snags Thermo Fisher’s Neuro Testing Lab Biz For $740 Mil.
Thermo Fisher Scientific is selling two diagnostic services units, including its Athena Diagnostics neurology testing business, for a total of $940 million, the company announced Feb. 24.
Abbott Recall Of Millions Of Glucose Test Strips Will Cost Under $20 Mil.
Abbott is recalling more than 350 million glucose testing strips used in several of its blood glucose monitoring systems because the strips may yield falsely low blood glucose results, FDA and the firm announced Dec. 22.